Nu-Med Plus, Inc. filed a Form 8-K on November 2, 2026, disclosing a Bylaws amendment requiring shareholder approval for any change of domicile out of Utah, and announcing its 2026 Annual Meeting of Shareholders scheduled for December 14, 2026.

Key Highlights

  • Bylaws amended November 2, 2026: The Board of Directors added a new section confirming that any transfer of the company's domicile to, or domestication in, a jurisdiction other than Utah requires approval by an affirmative majority vote of shares entitled to vote at a quorum-present meeting.
  • Utah statute cited: The amendment references Utah Code Ann. § 16-10a-1533.5 (or any successor statute) as the basis for the shareholder-approval requirement.
  • Annual Meeting set for December 14, 2026: The meeting will be held virtually, though the company reserves the right to change the date prior to that time.
  • Record date is November 6, 2026: Shareholders of record of the company's common stock at the close of business on that date are entitled to notice of and to vote at the Annual Meeting.
  • Shareholder proposal deadline is November 13, 2026: Any proposal or director nomination intended for inclusion in proxy materials, or submitted under the Bylaws for other business, must be received at the company's principal executive offices by the close of business on that date.
  • Signed by CEO William Hayde: The filing was signed on behalf of Nu-Med Plus, Inc. by William Hayde, Chief Executive Officer.

Nu-Med Plus Adds Domicile-Transfer Vote Requirement and Schedules Virtual 2026 Annual Meeting

According to the filing, Nu-Med Plus, Inc. (Commission File No. 000-54808), incorporated in Utah and headquartered at 640 Belle Terre, Building 2E, Port Jefferson, NY 11777, reported two principal actions under its Form 8-K dated November 2, 2026. The company's securities are not registered under Section 12(b) of the Act, and no exchange ticker symbol appears in the registered-securities table of the filing.

The Board of Directors amended the company's Bylaws effective November 2, 2026, to add a provision addressing domicile changes. The filing states that "pursuant to Utah Code Ann. § 16-10a-1533.5 (or any successor statute), any transfer of the Company's domicile to, or domestication of the Company in, a jurisdiction other than the State of Utah is required to be approved by the affirmative vote of a majority of the votes cast by the shares entitled to vote thereon, present in person or represented by proxy at a meeting at which a quorum is present." The full text of the amendment is filed as Exhibit 3.1 to the Current Report, and the filing notes that the summary "does not purport to be complete and is qualified in its entirety" by that exhibit.

Separately, the Board determined that the 2026 Annual Meeting of Shareholders will be held virtually on December 14, 2026, according to the filing, with the specific time and virtual location to be set forth in the company's definitive proxy statement. The company disclosed that it reserves the right to change both the meeting date and the record date of November 6, 2026. Shareholder proposals and director nominations, whether submitted under Rule 14a-8 or through the Bylaws, must be received at 640 Belle Terre Rd., Building 2 E, Port Jefferson, NY 11777, Attention: Corporate Secretary, by the close of business on November 13, 2026. The filing states that any proposal submitted after this deadline "will be considered untimely and not properly brought before the Annual Meeting."

What Was Disclosed

Nu-Med Plus, Inc. filed an 8-K on November 2, 2026, reporting a Bylaws amendment that mandates a majority shareholder vote for any out-of-Utah domicile change, and announcing a virtual Annual Meeting on December 14, 2026, with a November 6, 2026 record date and a November 13, 2026 shareholder proposal deadline.